{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:04:06Z","timestamp":1789967046733,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.semarthrit.2026.153076","type":"journal-article","created":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T14:11:51Z","timestamp":1789308711000},"page":"153076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Peripheral macrovascular thrombosis in catastrophic antiphospholipid syndrome (CAPS): A descriptive analysis from the \u201cCAPS Registry\u201d"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8814-1742","authenticated-orcid":false,"given":"Berta","family":"Vilaplana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Russa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Jerez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Pons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ponce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0646-9340","authenticated-orcid":false,"given":"Pilar","family":"Toledano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomeu","family":"Rossi\u00f1ol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignasi","family":"Rodr\u00edguez-Pint\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7216-677X","authenticated-orcid":false,"given":"Doruk","family":"Erkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1336-0163","authenticated-orcid":false,"given":"Gerard","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricard","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2026.153076_bib0001","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/bmj.287.6399.1088","article-title":"Thrombosis, abortion, cerebral disease, and the lupus anticoagulant","volume":"287","author":"Hughes","year":"1983","journal-title":"Br Med J"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0002","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMra002974","article-title":"The antiphospholipid syndrome","volume":"346","author":"Levine","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0003","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0049-3848(17)30066-X","article-title":"Antiphospholipid syndrome","volume":"151","author":"Cervera","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0004","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1749-8090-5-101","article-title":"Antiphospholipid syndrome: its implication in cardiovascular diseases: a review","volume":"5","author":"Koniari","year":"2010","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11926-021-01038-2","article-title":"Epidemiology of antiphospholipid syndrome in the general population","volume":"23","author":"Dabit","year":"2022","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0006","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0007","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0008","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0009","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0010","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.autrev.2006.06.005","article-title":"The catastrophic antiphospholipid (Asherson's) syndrome","volume":"6","author":"Asherson","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0011","first-page":"508","article-title":"The catastrophic antiphospholipid syndrome","volume":"19","author":"Asherson","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0012","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1191\/0961203303lu394oa","article-title":"Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines","volume":"12","author":"Asherson","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0013","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1136\/ard.2004.025759","article-title":"Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome","volume":"64","author":"Cervera","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0014","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/rheumatology\/key082","article-title":"The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients","volume":"57","author":"Rodr\u00edguez-Pint\u00f3","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0015","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.autrev.2016.09.010","article-title":"Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the International CAPS Registry","volume":"15","author":"Rodr\u00edguez-Pint\u00f3","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0016","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.autrev.2010.08.005","article-title":"Catastrophic antiphospholipid syndrome: updated diagnostic algorithms","volume":"10","author":"Erkan","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0017","doi-asserted-by":"crossref","first-page":"SI46","DOI":"10.1093\/rheumatology\/kead556","article-title":"What we know and what we don\u2019t know about catastrophic antiphospholipid syndrome","volume":"63","author":"Rodriguez-Pint\u00f3","year":"2024","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0018","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/eurjpc\/zwab088","volume":"29","author":"Mazzolai","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0019","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1196\/annals.1422.055","article-title":"Peripheral vascular occlusions leading to gangrene and amputations in antiphospholipid antibody positive patients","volume":"1108","author":"Asherson","year":"2007","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0020","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/acr.24468","article-title":"Characteristics of patients with antiphospholipid antibody positivity in the APS ACTION International Clinical Database and Repository","volume":"74","author":"Sevim","year":"2022","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0021","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10067-017-3549-1","article-title":"Clinical characteristics and laboratory findings of 252 Chinese patients with anti-phospholipid syndrome: comparison with Euro-Phospholipid cohort","volume":"36","author":"Shi","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0022","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1177\/0961203312446974","article-title":"Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): demographic features, risk factors, clinical and laboratory profile","volume":"21","author":"Bertero","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0023","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1177\/0961203320933009","article-title":"Long-term follow-up of antiphospholipid syndrome: real-life experience from a single center","volume":"29","author":"Serrano","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0024","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1538-7836.2009.03674.x","article-title":"Clinical course of high-risk patients diagnosed with antiphospholipid syndrome","volume":"8","author":"Pengo","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0025","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13075-022-02814-w","article-title":"Clinical characteristics and prognosis of patients with antiphospholipid antibodies based on cluster analysis: an 8-year cohort study","volume":"24","author":"Qi","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0026","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.semarthrit.2007.10.013","article-title":"Amputation of digits or limbs in patients with antiphospholipid syndrome","volume":"38","author":"Asherson","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0027","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1177\/1538574417729273","article-title":"Surgical interventions for organ and limb ischemia associated with primary and secondary antiphospholipid antibody syndrome with arterial involvement","volume":"51","author":"Hinojosa","year":"2017","journal-title":"Vasc Endovasc Surg"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0028","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(01)00619-2","article-title":"Cancer and the prothrombotic state","volume":"3","author":"Lip","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0029","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrclinonc.2012.106","article-title":"Thrombosis and cancer","volume":"9","author":"Young","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0030","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12185-024-03735-x","article-title":"The pathogenesis of cancer-associated thrombosis","volume":"119","author":"Tatsumi","year":"2024","journal-title":"Int J Hematol"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2023.152265","article-title":"Pulmonary involvement in catastrophic antiphospholipid syndrome: a descriptive analysis from the \u201cCAPS Registry\u201d","volume":"63","author":"Ponce","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0032","doi-asserted-by":"crossref","first-page":"E153","DOI":"10.1503\/cmaj.160142","article-title":"Thrombotic microangiopathies: a general approach to diagnosis and management","volume":"189","author":"Arnold","year":"2017","journal-title":"CMAJ"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103173","article-title":"Phenotypes in antiphospholipid syndrome: a hierarchical cluster analysis based on two independent databases","volume":"144","author":"Taieb","year":"2024","journal-title":"J Autoimmun"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0034","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1016\/j.jtha.2025.06.010","article-title":"Identification of phenotypes in thrombotic primary antiphospholipid syndrome using cluster analysis: a step toward personalized medicine","volume":"23","author":"Santos","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.semarthrit.2026.153076_bib0035","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.3390\/brainsci11121641","article-title":"Cerebral vein thrombosis in the antiphospholipid syndrome: analysis of a series of 27 patients and review of the literature","volume":"11","author":"Jerez-Lienas","year":"2021","journal-title":"Brain Sci"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226001666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017226001666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:17:55Z","timestamp":1789964275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017226001666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":35,"alternative-id":["S0049017226001666"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.153076","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral macrovascular thrombosis in catastrophic antiphospholipid syndrome (CAPS): A descriptive analysis from the \u201cCAPS Registry\u201d","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2026.153076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153076"}}